Pazopanib is a new cancer drug that works by limiting the growth of new blood vessels in
tumours. About half of patients who take pazopanib develop high blood pressure
(hypertension). This side effect can make patients have to reduce or stop their cancer
treatment, and can cause other health problems. The aim of this study is to find out exactly
how the drug causes high blood pressure.
Phase:
Phase 2
Details
Lead Sponsor:
Cambridge University Hospitals NHS Foundation Trust